Research dossier
Adamax — combined-formulation dossier and the limits of attribution
A combined formulation: each component has to be characterised separately.
Translated from the French original, which remains the reference version: lire en français →
Molecular identity
| Parameter | Value |
|---|---|
| CAS number | N/A (research blend) |
| Molar mass | Variable |
| Molecular formula | Heptapeptide research blend |
| Sequence / nature | N-Acetyl-Semax-Amidate gemodificeerd |
| Purity | ≥99% |
| Appearance | White lyophilised powder |
The values above correspond to the catalogue lot and are reproduced as they stand from the product page. Any discrepancy between this dossier and the product page should be reported before use.
Research context
Combined formulations raise a general methodological question, independent of what they contain: what can be concluded from an observation made on a mixture? The answer is restrictive, and this material serves above all to illustrate the need for per-component control arms.
Mechanism studied
Adamax is a combined formulation, not a single molecular entity. That distinction is decisive both analytically and for the interpretation of any result.
A mixture has no CAS number of its own, no single molecular mass, and its chromatographic profile shows as many principal peaks as it has components. The purity of a mixture therefore cannot be read the way the purity of an isolated compound is: what is measured is the purity of each constituent and the ratio between them.
Experimentally, a mixture introduces an irreducible confounding variable: an effect observed in culture cannot be attributed to one of the components without a control arm exposing the cells to that component alone. Any publication dealing with a combination that lacks those controls supports no conclusion about an individual contribution.
This methodological limit has to be stated explicitly in any protocol using this material.
In-vitro literature
There is no in-vitro body of work addressing this formulation as such. The available literature concerns the components taken in isolation, and transposing it to the combination is hypothesis rather than observation.
Bibliographic entry points
- PubMed — peer-reviewed literature
- PubChem — chemical profile and assay data
- NCBI — methodology and receptor references
These links are an entry point into the literature, not an edited selection. None of the sources cited relates to a human use of this material, and consulting them directly is recommended for any protocol design.
Distinguishing this compound from its analogues
Not being a single molecular entity, this material has neither a CAS number nor a molar mass of its own. Any source that assigns it one should be treated with caution.
The CAS number shown on the product page is the identifier to rely on. Trade names, development codes and customary abbreviations vary from one source to another and are not a reliable identification.
Methodological limits
A combined formulation permits no causal attribution without a control arm for each isolated component. That is the structuring limit of any protocol using this material, and no choice of measurement can lift it.
These limits are not formalities: they determine what a protocol using this material can and cannot establish. Making them explicit in the experimental plan avoids attributing to the compound an observation that belongs to the measurement system.
Analytical parameters
Analytical control covers the identification and quantification of each constituent. The Janoshik report for the 10 mg presentation can be consulted from the product page.
| Parameter | Value |
|---|---|
| Storage | Store at −20 °C, protected from light |
| Solubility | Soluble in bacteriostatic water (BAC) |
| Stability | Stable for 24 months at −20 °C; 30 days after reconstitution at 2–8 °C |
| Control methods | RP-HPLC · MS · NMR |
Reconstitution is a matter for the experimental protocol. The volume of solvent determines the final concentration and is not prescribed here: it depends on the design of the experiment and the conditions of the assay.
Resulting concentrations
The table below is arithmetic: it gives the concentration obtained for a given solvent volume, with no recommendation of use.
| Format | 1 ml | 2 ml | 3 ml |
|---|---|---|---|
| 10mg | 10.00 mg/ml | 5.00 mg/ml | 3.33 mg/ml |
These values assume complete dissolution and a peptide content consistent with the lot report. Where the actual quantitative content differs from the nominal mass — a common discrepancy, caused by counter-ions and residual water — the effective concentration is lower than the theoretical value. That is precisely why quantitative content per vial forms part of the verification protocol.
Protocol design
Three points govern the validity of an assay using this material, whatever the question being asked.
The effective concentration is not the nominal concentration. It depends on the actual peptide content of the lot, on complete dissolution and on adsorption to the walls of the container. A concentration check after reconstitution is preferable to assuming a perfect yield.
The actual exposure time may be shorter than the nominal duration where the compound is degraded by the medium. Verify stability under the exact conditions of the assay — medium, serum, temperature, duration — before interpreting an absence of effect.
The control arm must correspond to the vehicle actually used, at the same final concentration. This requirement is unremarkable and remains the most frequent cause of irreproducible results.
Lot verification
The Janoshik certificates of analysis for the catalogue are collected in the lot report register.
The following formats are covered by a Janoshik Analytical report, readable from the product page:
- 10mg — lot report available
| Format | Lot report | Availability |
|---|---|---|
| 10mg | Covered | In stock |
The verification programme covers exclusively the identity and purity of the material, by reversed-phase chromatography and mass spectrometry. It covers neither sterility, nor endotoxins, nor any microbiological characteristic.
Frequently asked questions
How does this product arrive?
As a lyophilised powder in a sealed vial, shipped in insulated, plain packaging. Return the vial to the storage temperature given in the specifications on receipt.
Which solvent should be used for reconstitution?
Bacteriostatic water is the usual reconstitution solvent for lyophilised peptides in a laboratory setting. The volume is a matter for the experimental protocol and the concentration sought; we provide no dosage recommendation.
How long does the material remain stable?
The stability window appears in the specifications table on this page, before and after reconstitution. Those values correspond to the storage conditions stated; any temperature variation shortens them.
Does the analysis report correspond exactly to my vial?
The report linked on this page corresponds to the format selected. Each report is issued by Janoshik Analytical from an anonymously submitted sample, and covers the identity and purity of the peptide.
Can this product be used on humans or animals?
No. It is an analytical grade reference material intended exclusively for in-vitro laboratory research. Any administration to humans or animals is excluded, and no therapeutic, diagnostic or medical claim is made.